Company intelligence / Profile preview

Novilytic

West Lafayette, Indiana, United States

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Novilytic’s Proteometer platform provides near-real-time molecular structure analysis for proteins, removing sample prep and enabling rapid, automated analysis for drug development and quality control; it has been validated in pharmaceutical manufacturing for efficiency, speed, and specificity in real-world settings

Therapeutic areas: Other
Modalities: ProteinMonoclonal antibody
Industry: Drug Discovery Services

Partnerships

Multiple large analytical instrument companiesAI leadersPharmaceutical consortiumsPurdue Research Foundation

Beyond the preview

Go deeper on Novilytic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novilytic.

Explore the full profile